It is somehow recognized that response of Graves' orbitopathy (GO) to immunosuppressive treatments parallels its activity [1] . In other autoimmune conditions, such as type 1 diabetes, response has been ascribed to a reduction in lymphocytes infiltrating the target organ [2] . In a recent study we assessed the relationship between the immunohistochemical phenotype of orbital lymphocytes and the ophthalmological features of GO [3] . We found that orbital infiltrating lymphocytes, which were present in ~ 50% of patients and were often organized into distinct foci, comprised a mixture of T (CD3-positive) and B (CD20-positive) cells, suggesting a mature, polyclonal autoimmune response. The total number of infiltrating lymphocytes, as well as the number of CD3-and CD20-positive cells correlated with the GO clinical activity score (CAS), both in single and multiple regression models, thereby suggesting a correlation between lymphocytes infiltrating orbital tissues and the activity of GO, and possibly enhancing our understanding of the relationship between GO immunological features and clinical expression [3] .
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Based on the above mentioned observations, we considered the possibility that not only orbital infiltrating lymphocytes correlate with CAS, and that also peripheral, circulating lymphocytes do so. To investigate this possibility, we conducted a cross-sectional investigation in consecutive patients with Graves' disease (GD), the results of which we briefly report here. Upon signed informed consent, we studied 81 consecutive subjects with GD (15 men and 66 women, aged 46.9 ± 12.8 years), of whom 48 had a clinically evident GO and 33 had no GO. The total number of circulating lymphocytes was measured in all patients, as well as the number of CD20-positive lymphocytes, the latter assessed by FACS analysis. The primary objective of the study was the relationship between peripheral lymphocytes and CAS within GO patients. The secondary objectives were the relationships between peripheral lymphocytes and: (1) GO severity; (2) presence/absence of GO in GD patients; and (3) anti-thyroid autoantibodies, namely anti-thyroglobulin, antithyroperoxidase, and anti-TSH receptor. In contrast with our hypothesis, the total number of peripheral lymphocytes as well as the number of CD-20-positive lymphocytes did not correlate with GO activity and severity, both by univariate and multivariate analyses, nor with the presence/absence of GO in GD patients, and nor with the levels and prevalence of serum anti-thyroid autoantibodies.
Based on our findings, we conclude that although orbital infiltrating lymphocytes seem to play a pathogenetic role in GO and are correlated with GO activity, peripheral lymphocyte have a marginal role, as suggested by the absence of a relationship with the presence and the clinical features of GO, even though they likely comprise the cell subsets that are responsible for orbital infiltration and that likely triggers the pathologic changes of the orbit and ultimately the clinical features of GO.
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